Revvity Inc.
RVTY
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.92B
Close$
$76.54
34.1% downside
Current Fair Value
34.1% downsideOvervalued by 34.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.92 Billion |
|---|---|
| Enterprise Value | $16.24 Billion |
| Dividend Yield | $0.28 (0.22%) |
| Earnings per Share | $2.08 |
| Beta | 1.07 |
| Outstanding Shares | 111,746,000 |
Return
| Return on Equity | 3.29% |
|---|---|
| Return on Assets | 1.97% |
| Return on Invested Capital | 3.31% |
Valuation & Multiples
| P/E Ratio | 59.4 |
|---|---|
| PEG | -1506 |
| Price to Sales | 4.47 |
| Price to Book Ratio | 1.82 |
| Enterprise Value to Revenue | 5.58 |
| Enterprise Value to EBIT | 45.61 |
| Enterprise Value to Net Income | 68 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.46 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$1.21
Average shareholder expectationRevenue Estimate
$702.96 M
Average shareholder expectationNext Earnings Call
Expected Date
October 26, 2026
EPS Estimate
$1.29
Average shareholder expectationRevenue Estimate
$694.07 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4904▼ 1150.33% |
|---|---|
| Total Calls | 78,500▲ 23.10% |
| Total Puts | 38,500▼ 94.97% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 102.70%▼ 0.52% |
|---|---|
| Total Invested | $12.79B▲ 26.40% |
| Investors Holding | 546▲ 36.00% |
ESG Score
No data
About Revvity Inc.
16,700 employees
CEO: Prahlad Singh PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...